Life Science Company News
Back to overview

Global Intravenous (IV) Iron Drugs Market 2012-2022 by Value, Therapeutic Application & Product Type

DUBLIN, Feb. 14, 2018 /PRNewswire/ --

The "Global Intravenous (IV) Iron Drugs Market: Analysis By Therapeutic Application, By Product Type, By Region, By Country (2018 Edition): Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.


Global market is projected to display a robust growth represented by a CAGR of 11.19% by value during 2017 - 2022, chiefly driven by increase in healthcare spending and rising prevalence of diseases with Iron deficiency, emerging second & third generation IV Iron drugs and growing middle class income group coupled with rising health consciousness.

Over the recent years, the global Intravenous (IV) Iron Drug industry has been driven by the rising high prevalence of Iron Deficiency with unfulfilled need, rising awareness, growing prevalence of diseases leading to severe Iron Deficiency and increasing healthcare expenditure in emerging economies. Globally, the growth in IV Iron drug market is driven by growing middle class population group demanding better drugs to improve lifestyle.

Among the therapeutic application type, nephrology accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large population suffering with Iron Deficiency and unfulfilled need, improving access to healthcare, changing lifestyle and expanding middle class income group.

Scope of the Report




  • Global IV Iron Drug Market, By Value
  • By Therapeutic Application (Nephrology, Gynecology & Obstetrics, Gastroenterology, Oncology, Cardiology, Others); By Value
  • By Product Type (Ferric carboxymaltose, Iron Sucrose, Iron Dextran and Others), By Value

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. I.V. Iron Drug Market Outlook

5. Global I.V. Iron Drug Market: Growth and Forecast

6. North America I.V. Iron Drug Market: Growth and Forecast

7. Europe I.V. Iron Drug Market: Growth and Forecast

8. Asia Pacific I.V. Iron Drug Market: Growth and Forecast

9. ROW I.V. Iron Drug Market: Growth and Forecast

10. Market Dynamics

11. Market Restraints

12. SWOT Analysis - I.V. Iron Drug Market

13. Porter's Five Forces Analysis - I.V. Iron Drug Market

14. Policy and Regulations

15. Company Profiles

  • AMAG Pharmaceuticals Inc
  • Allergan PLC
  • Daiichi Sankyo Company Limited
  • Galenica
  • Nippon Shinyaku CO. LTD
  • Pharmacosmos A/S
  • Sanofi

For more information about this report visit https://www.researchandmarkets.com/research/rqb769/global?w=5

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



Cision View original content:http://www.prnewswire.com/news-releases/global-intravenous-iv-iron-drugs-market-2012-2022-by-value-therapeutic-application--product-type-300598622.html

SOURCE Research and Markets

By: PR Newswire Association LLC. - 14 Feb 2018
Back to overview

Enhance your business development with Biotechgate
Try for free »